Tempest Therapeutics (FRA:3OS0) Tariff Resilience Score: 9/10 (As of Jul. 02, 2026)


FRA:3OS0 Tempest Therapeutics Inc FRA:3OS0
32 GF Score
Price €5.82
! 1 Warning Sign
View Full Analysis

What is Tempest Therapeutics Tariff Resilience Score?

Tempest Therapeutics FRA:3OS0 32 Tariff Resilience Score is 9 as of Jul. 02, 2026. GuruFocus rates FRA:3OS0 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,374 Biotechnology companies, Tempest Therapeutics ranks better than 99.93% on this metric.

Tempest Therapeutics has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Tempest Therapeutics has Tempest Therapeutics, a biotech firm, has minimal exposure to tariffs as its operations are primarily research-focused with limited international trade dependencies. Historical data shows negligible impact from tariffs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Tempest Therapeutics might have Highly Resilient.

Tempest Therapeutics  (FRA:3OS0) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Tempest Therapeutics Tariff Resilience Score Related Terms

FRA:3OS0 vs HOWL, INTI, GTBP: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Tempest Therapeutics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tempest Therapeutics Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tempest Therapeutics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Tempest Therapeutics's Tariff Resilience Score falls into.


FRA:3OS0
32GF Score
Tempest Therapeutics Inc FRA:3OS0
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Tempest Therapeutics (FRA:3OS0) has a Tariff Resilience Score of 9 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Tempest Therapeutics ranks #1 out of 1374 companies in the Biotechnology industry, placing it in the top 0.099999999999994%.
Is Tempest Therapeutics' Tariff Resilience Score too high?
Tempest Therapeutics' current Tariff Resilience Score is 9. The Biotechnology industry median Tariff Resilience Score is 4.00. Tempest Therapeutics' value of 9 is 125% above this industry median. Based on the distribution chart, Tempest Therapeutics ranks #1 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Tempest Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Tempest Therapeutics' Tariff Resilience Score compare to HOWL and INTI?
According to the Biotechnology industry distribution chart, Tempest Therapeutics ranks #1 out of 1374 companies for Tariff Resilience Score. This places Tempest Therapeutics in the top 0% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Tempest Therapeutics' value of 9 is 125% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tempest Therapeutics's current Tariff Resilience Score of 9 is 125% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tempest Therapeutics's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tempest Therapeutics stock overvalued right now?
Tempest Therapeutics (FRA:3OS0) has a current Tariff Resilience Score of 9. The current Tariff Resilience Score is 9 and 125% above the Biotechnology industry median of 4.00. Tempest Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Tempest Therapeutics (FRA:3OS0), the current Tariff Resilience Score is 9 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tempest Therapeutics Business Description

Other Exchanges TPST:USA
Address 2000 Sierra Point Parkway, Suite 400, Brisbane, CA, USA, 94005
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.
32GF Score

Get the complete analysis for FRA:3OS0

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.82
Price